chloroquine has been researched along with Dyslipidemia in 1 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dyslipidemia is a common disorder in systemic lupus erythematosus (SLE) patients." | 2.61 | Impact of antimalarial (AM) on serum lipids in systemic lupus erythematosus (SLE) patients: A systematic review and meta-analysis. ( Chen, T; Cheng, GY; Jiang, YM; Liu, D; Shang, J; Tao, CY; Xiao, J; Yu, D; Zhao, ZZ, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tao, CY | 1 |
| Shang, J | 1 |
| Chen, T | 1 |
| Yu, D | 1 |
| Jiang, YM | 1 |
| Liu, D | 1 |
| Cheng, GY | 1 |
| Xiao, J | 1 |
| Zhao, ZZ | 1 |
1 review available for chloroquine and Dyslipidemia
| Article | Year |
|---|---|
Impact of antimalarial (AM) on serum lipids in systemic lupus erythematosus (SLE) patients: A systematic review and meta-analysis.
Topics: Adult; Antimalarials; Chloroquine; Dyslipidemias; Female; Humans; Hydroxychloroquine; Lipids; Lupus | 2019 |